Clinical Evaluation

A study conducted by the National Association of Sports Medicine Specialists at G.D Annunzio University in Italy found that pharmacological treatments w ere intensified when delivered with the CTU-Mega 18 Diamagnetic Device.

Clinical Evaluation

The researchers found that the CTU-Mega 18 Diamagnetic Device is “an innovative system for the implant of pharmacological active molecules... allowing an active transport of a remarkable amount of molecules even to a depth of 12 cm”. (1)


There was also a clinical evaluation at the Professional Studio of Physiotherapy and Sportive Rehabilitation in Piacenza d’Adige , conducted on 132 patients with osteoarthritis (OA).

Clinical Evaluation

 

The patients had undergone cycles of treatment with the CTU-Mega 18 Diamagnetic Device for a minimum of 5 to a maximum of 12 sessions, according to the pathology. The first 4 sessions of the treatment were carried out with an interval of 5 days, the rest every 10 days. (2)

 

Ref (1) : Ferretti T., “Recent progresses as far as the diamagnetic acceleration is concerned” Molecular penetration: new therapeutic proposals for physical trauma, XXI National Congress of Sport Activities and Neuromuscular Pathology 2005

Ref (2): Coordinated by Dr. Loris Stella, during the period between 1st March 2005 and 30th September 2005 for PANACEA Research.